|
C20ORF177 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.89730000005528E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.448300E-04 |
| Normal-vs-Stage2 |
6.805800E-02 |
| Normal-vs-Stage3 |
2.21769999999566E-05 |
| Normal-vs-Stage4 |
1.73663999999407E-05 |
| Stage1-vs-Stage2 |
8.056600E-01 |
| Stage1-vs-Stage3 |
1.135240E-01 |
| Stage1-vs-Stage4 |
5.932100E-02 |
| Stage2-vs-Stage3 |
2.437200E-01 |
| Stage2-vs-Stage4 |
1.843190E-01 |
| Stage3-vs-Stage4 |
7.083800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.52190000000308E-05 |
| Normal-vs-AfricanAmerican |
5.65969999977156E-07 |
| Normal-vs-Asian |
5.837600E-01 |
| Caucasian-vs-AfricanAmerican |
1.878030E-02 |
| Caucasian-vs-Asian |
4.342000E-01 |
| AfricanAmerican-vs-Asian |
8.499500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.24620000000209E-05 |
| Normal-vs-Female |
4.40820000000564E-05 |
| Male-vs-Female |
5.272600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.382100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.551080E-04 |
| Normal-vs-Age(61-80Yrs) |
3.52590000000097E-05 |
| Normal-vs-Age(81-100Yrs) |
1.597150E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.115400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.258600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.831600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.215000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.811000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.031400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.572580E-01 |
| Normal-vs-Grade 2 |
2.159200E-03 |
| Normal-vs-Grade 3 |
3.82799999998351E-06 |
| Normal-vs-Grade 4 |
2.96280000000593E-06 |
| Grade 1-vs-Grade 2 |
8.863400E-01 |
| Grade 1-vs-Grade 3 |
4.396200E-01 |
| Grade 1-vs-Grade 4 |
1.891000E-01 |
| Grade 2-vs-Grade 3 |
9.924300E-02 |
| Grade 2-vs-Grade 4 |
1.765950E-02 |
| Grade 3-vs-Grade 4 |
1.919580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.497800E-03 |
| Normal-vs-ccB subtype |
5.846100E-04 |
| ccA subtype-vs-ccB subtype |
2.886800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.832100E-04 |
| Normal-vs-N1 |
4.296400E-01 |
| N0-vs-N1 |
6.571400E-01 |
|
|
